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The lung is a unique immunologic organ, responding to
infectious, antigenic or toxic insults with specific humor-
al, cellular, and tissular mechanisms while maintaining
its primary biologic functions [1]. It has been recognized
more recently that other types of aggression lead to a
significant activation of inflammatory mechanisms with-
in the lung. For instance, direct or indirect severe trauma
results in acute inflammation of the pulmonary paren-
chyma in a significant proportion of patients. These
changes are characterized by massive leukocyte segrega-
tion in lung capillaries and interstitial space, as well as a
marked leak of plasma and blood cells into the interstiti-
um. This inflammatory reaction is associated with signif-
icant changes in pro- and anti-inflammatory cytokine
levels in bronchoalveolar lavage (BAL) fluid [2]. These
mediators seem to play essential roles in the lung tissue
changes, as their local concentrations are significantly
higher than in the systemic circulation. A few exceptions
exist, however: in ARDS secondary to septic shock due
to an extrapulmonary infection, for instance, serum lev-
els of proinflammatory cytokines can increase as much
as intrapulmonary values [3]. The inflammatory tissue
reaction can be of short duration and self-limiting, prob-
ably due to a subtle autoregulation and balance between
pro- and anti-inflammatory mediators and repair mecha-
nisms. The resulting features of cellular infiltration, tis-
sue remodelling, and healing seem to be quite similar to
other types of wounds and their healing [4]. In relatively
rare cases, lung inflammation can persist for weeks, even
without clear-cut superinfection, and persistently high
BAL and/or plasma levels of proinflammatory cytokines
seem to indicate a poor outcome [5].
The latest addition to the list of identified agents ca-
pable of inducing significant inflammatory lung injury is
mechanical ventilation (MV), above all if higher tidal
volumes and lower positive end-expiratory pressure
(PEEP) levels are used [6, 7]. Although it has been
known for a long time that damage to pulmonary tissue
and airways can occur during prolonged MV, it has only
become clear during recent years that not only are me-
chanical forces responsible for alveolar rupture and air-
way dilatation, but also acute inflammation is involved.
MV with “normal” or high tidal volumes leads to ac-
tivation of leukocytes such as macrophages, monocytes,
and polymorphonuclear cells, but possibly also to stimu-
lation of alveolar pneumocytes I and airway epithelial
cells, with a consecutive production of cytokines of the
TNFα, IL-1β, IL-6 or IL-8 type, and a number of others.
Stretching cultured human macrophages in a plastic
chamber by positive pressure ventilation results in a sig-
nificant production of pro-inflammatory cytokines when
endotoxin is present [8]. MV of isolated perfused lungs
produces increased pulmonary cytokines and transloca-
tion of nuclear factor-κB, which are effects similar to
these observed after endotoxin infusion [7, 9].
From earlier work in humans, i.e., critically ill pa-
tients requiring MV, it seems clear that marked changes
in cytokine levels and leukocyte count can be observed
in BAL over a time period of 1–3 days [10]. Less is
known about shorter periods of MV, both in terms of
lung injury and inflammatory changes.
This gap in knowledge is beginning to be filled by
work such as the one published in this issue of Intensive
Care Medicine by Frans B. Plötz and his colleagues [11].
These authors have studied twelve infants undergoing di-
agnostic cardiac catheterization. The short-term effects
of MV using a VT of 10 ml/kg and a PEEP of 4 cmH2O
on intrapulmonary levels of pro- and anti-inflammatory
mediators were assessed, as well as the associated
changes in the capacity of leukocytes collected from the
systemic circulation to produce interferon IFNγ, TNFα,
and IL-6, and finally the killing activity of systemic nat-
ural killer (NK) cells. The authors observed an increase
in TNFα and IL-6 levels in BAL, but no significant
changes in IL-8 and the anti-inflammatory cytokines IL-
10 and IFNγ. In systemic blood, the capacity of lympho-
cytes to produce IFNγ was decreased and, after LPS
stimulation, monocytes released less IL-6 and TNFα; in
addition, the killing activity of NK cells was decreased.
How do these findings fit into the concept of the re-
sponse of the lung tissue to insults such as trauma or
MV? First, the results reported by Plötz et al. confirm
the early inflammatory reaction to positive pressure ven-
tilation seen in isolated lungs [7, 9], experimental ani-
mals subjected to high VT and low PEEP ventilation
[12], and ICU patients [10]. Second, the data presented
indicate that 2 h of MV is sufficient in these children to
initiate significant changes in the local and systemic im-
mune status. Third, their work suggests that further stud-
ies in children and adults are warranted – not only to
confirm the results reported here, but also to define if
different techniques of MV (e.g., lower tidal volume,
higher PEEP) lead to a different pulmonary and systemic
immune response. In addition, the specific roles of MV,
anesthesia, and other interventions such as surgery
should be investigated further.
There is another important consideration which should
be included in this discussion. Indeed, the effects of a lo-
cal inflammatory reaction on systemic immune status are
not well explored. On the one hand, an overflow or a
translocation of mediators and activated cells from the
site of inflammation into the systemic circulation and to
distant organs have been observed, inducing systemic
signs of inflammation such as fever, hyperdynamic car-
diovascular state, and leukocytosis as well as vital organ
dysfunctions [13]. On the other hand, it has been suggest-
ed that local inflammation could be coordinated with sys-
temic antiinflammation, thereby allowing the body to lo-
calize activated leukocytes at the injured local site [14].
This reaction could protect uninvolved organs and tissues
from the damaging effects of mediators and activated
cells, but it may also be immunosuppressive.
There are some data confirming a strong local pro-
inflammatory activity in acute lung injury, assessed by
BAL, whereas no such activity was detected in systemic
blood [15]. Another clinical example of systemic immu-
nosuppression (also called immune paralysis) occurs in
the trauma patient: lymphocyte function can be impaired
and these patients are at increased risk for infection, sep-
sis, and death [16]. In critically ill patients undergoing
non-protective methods of MV and presenting with in-
creased signs of intrapulmonary inflammation as as-
sessed by BAL fluid, higher plasma levels of IL-6 (a cy-
tokine considered to have significant antiinflammatory
characteristics), more vital organ dysfunctions and a
higher mortality have been observed [17, 18].
Any therapeutic consequences? If confirmed, the data
of the present [11] and further studies could change the
methods and techniques of MV used to allow short- or
longer-term diagnostic or therapeutic interventions under
anesthesia. It could be possible that even short-term MV
should be conducted using a lung-protective strategy. On
the other hand, millions of patients undergo MV during
general anesthesia each week around the world, and little
clinical evidence is available suggesting this is harmful
for subsequent respiratory and other organ function. Re-
cently, a clinical study did not reveal an increase in plas-
ma levels of pro- or antiinflammatory cytokine levels af-
ter 1 h of mechanical ventilation with 15 or 6 ml/kg bw
tidal volume [19].
However, the absence of clinically visible harmful ef-
fects of MV with normal tidal volume should not stop
clinical investigators from looking into mechanisms pro-
ducing acute lung inflammation and systemic depression
of immune defences, because superinfection is a well-
recognized complication after this type of intervention.
The susceptibility and mechanisms of infection have
been clarified to some extent, but more work must be
done to improve our understanding, and thereby the
means for prevention.
In conclusion, Plötz et al. report important changes in
the immune response in children after only 2 h of MV 
– fire in the lung and icy peripheral leukocytes – a con-
firmation of a systemic immunosuppression in response
to acute lung inflammation?
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